We analysed two trials with 12 999 participants and 71 events for the non-steroidal mineralocorticoid receptor antagonists, which probably increase the risk of hyperkalaemia leading to admission to hospital (odds ratio 5.92, 95% confidence interval 3.02 to 11.62; moderate certainty). Here, NR3C2 is linked to Hyperkalemia.